Related Experiment Videos
Presentation of results from bioequivalence studies
R Sauter1, V W Steinijans, E Diletti
1Department of Biometry, Byk Gulden Pharmaceuticals, Konstanz, Germany.
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|January 1, 1992
Summary
This study provides recommendations for presenting bioequivalence study results, offering a detailed standard for research reports and a concise subset for publication to enhance clarity and speed up peer review.
Area of Science:
- Pharmacokinetics and Drug Development
- Clinical Trial Design and Analysis
- Pharmaceutical Regulatory Science
Background:
- Standardized reporting is crucial for bioequivalence studies.
- Current presentation methods can vary, impacting interpretation.
- Guidelines exist but specific result presentation needs refinement.
Purpose of the Study:
- To propose standardized formats for presenting bioequivalence study results.
- To offer recommendations for both comprehensive research reports and concise publications.
- To improve the clarity, consistency, and efficiency of bioequivalence study dissemination.
Main Methods:
- Development of presentation recommendations based on general bioequivalence study guidelines.
- Illustration of recommendations using two examples: single-dose and multiple-dose studies.
- Differentiation between a complete results presentation and a subset for publication.
Main Results:
- A comprehensive template for detailed bioequivalence study results is provided.
- A standardized, essential subset of results for publication is suggested.
- The proposed formats aim to facilitate bioequivalence assessment and interpretation.
Conclusions:
- Standardized presentation of bioequivalence data enhances scientific communication.
- A complete dataset submission aids peer review and reproducibility.
- Adoption of these recommendations can improve and harmonize bioequivalence publications.